MIAMI, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication Pharmacy Times around the company’s proprietary new Tele-PharmCo platform. Progressive Care Inc. CEO S. Parikh Mars will give the first-ever live demonstration of the Company’s Tele-PharmCo platform during her presentation titled Tele-Pharmacy: Where Personalization Meets Tech at the 5th Annual Florida Telehealth Summit on November 8, 2018 from 3:15 p.m. – 4:15 p.m. ET at the Trade Winds Island Resort in St. Pete Beach, Florida.
In an article published October 18, 2018, in Pharmacy Times, Mars discusses the beta launch of the company’s new proprietary tele-pharmacy software, Tele-PharmCo. The article, titled New Tele-Pharmacy Software Offers Face to Face Interaction Between Pharmacists and Patients, also discusses the potential the new interface has for revolutionizing patient-to-pharmacist interaction.
The article quotes Mars saying, “Tele-PharmCo will allow the patients to have access to the pharmacist just the way they would if they walked in. It’s the same quality… It helps for patients to see us. It’s not just a stranger over the phone—it’s someone who cares. It’s someone who’s going to address them by name.”
The new multi-platform technology software will facilitate two-way video conferencing between patients, healthcare professionals, and PharmCo’s team of pharmacists and pharmacy technicians through a secure video interface. Tele-PharmCo will allow patients and their care providers to connect and interact with licensed pharmacists and pharmacy technicians in real time and speak directly about medications, prescription refills, adverse reactions, and other concerns.
“We are honored to have Progressive Care’s proprietary Tele-PharmCo software highlighted in such a relevant industry publication,” said S. Parikh Mars, CEO of Progressive Care Inc. “The lack of personalized patient interaction in the U.S. ends up leading to avoidable healthcare costs and health complications. This platform will give patients an experience comparable with walking up to an actual pharmacy window. We are committed to developing groundbreaking technologies that set the industry standard to improve patient adherence and offer the best services possible. Through our custom compounding, free delivery services, smart pack packaging, and expanding tele-pharmacy platform, we are focused on continuing to improve patient outcomes.”
Initially, the Tele-PharmCo software will be made available on customized kiosks, iPad devices, and desktop platforms, with plans to roll out a mobile application in the coming months. Progressive Care will be strategically identifying senior living communities, long-term care facilities, clinics, and physician’s offices for the software-enabled devices to be made available.
The software is also being integrated into the company’s DischargeRx program for hospital transitional care management. The DischargeRx program has currently been in use at Westchester General Hospital in Miami, Fla. since July of this year.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Tory Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com